News tagged with pulmonary fibrosis

Related topics: lung · american journal of respiratory and critical care medicine

World first trial of shark inspired drug

La Trobe University scientists are preparing to run a world-first clinical trial of a new drug inspired by shark antibodies. The drug, AD-114, is a human protein that is based on the shape of an antibody of a Wobbegong shark.

Jan 31, 2017
popularity2 comments 0

Protein may be crucial in many lung ailments

The more proteins that prove essential in the pathways of disease, the more targets drug makers and doctors have for intervention. That's why its potentially important that a new study reports a key role for the protein TMEM219 ...

Sep 16, 2016
popularity53 comments 0

Interstitial lung disease

Interstitial lung disease (ILD), also known as diffuse parenchymal lung disease (DPLD), refers to a group of lung diseases affecting the interstitium (the tissue and space around the air sacs of the lungs). It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissues.

The term ILD is used to distinguish these diseases from obstructive airways diseases.

Most types of ILD involve fibrosis, but this is not essential. The term "pulmonary fibrosis" is no longer considered a synonym. Idiopathic pulmonary fibrosis is one form of "interstitial lung disease".

This text uses material from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed